Despite challenges such as high attrition rates and adverse events, the trial highlights the value of established therapies ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics Ltd. has amended its company constitution, highlighting key changes in share capital and shareholder rights. These ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

The pharmaceutical company also has platforms for the discovery of B cell therapies, chimeric antigen receptor T cell therapies, and chicken antibody therapies. The US Food and Drug Administration ...

Weʼre unable to load stories right now.

The full indication for vilobelimab is as a treatment for adult patients with SARS‑CoV-2‑induced ARDS who are receiving ...

1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. 9Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York ...

Infliximab is a chimeric monoclonal antibody against tumour-necrosis factor-α (TNF-α), which has demonstrated efficacy in patients who do not respond to traditional therapies 2,4. Since then ...

Investment analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued on Saturday. The brokerage set a “hold” rating on ...